Resistance trends in gram-negative bacteria: Surveillance results from two Mexican hospitals, 2005-2010

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Morfin Otero, Rayo ^a,b   Tinoco Favila, Juan Carlos ^c   Sader, Helio S ^d   Salcido Gutierrez, Lorena ^c   Perez Gomez, Hector Raul ^a,b   Gonzalez Diaz, Esteban ^a,b   Petersen, Luis ^a   Rodriguez Noriega, Eduardo ^a,b  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^c Hospital General de Durango   (Mexico)

^d JMI LABORATORIES   (United States)

Author keywords

Bacterial; Gram negative; Infections; Nosocomial; Resistance

Indexed keywords

ACINETOBACTER; BACILLI (CLASS); BACTERIA (MICROORGANISMS); ENTEROBACTER; ESCHERICHIA COLI; KLEBSIELLA; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; EPIDEMIOLOGICAL MONITORING; GRAM NEGATIVE BACTERIUM; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; MEXICO; MICROBIAL SENSITIVITY TEST; PHENOTYPE; STATISTICS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; GRAM-NEGATIVE BACTERIA; HOSPITALS; HUMANS; MEXICO; MICROBIAL SENSITIVITY TESTS; PHENOTYPE;

EID: 84861905187     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-277     Document Type: Article

References (26)

1. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK, Infect control hosp epidemiol 2008 29 11 996 1011 10.1086/591861 18947320
2. Hospital-acquired infections due to gram-negative bacteria. Peleg AY, Hooper DC, N Engl J Med 2010 362 19 1804 1813 10.1056/NEJMra0904124 20463340
3. Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008. Kallen AJ, Hidron AI, Patel J, Srinivasan A, Infect Control Hosp Epidemiol 2010 31 5 528 531 10.1086/652152 20334552
4. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D'Inzeo T, Fadda G, Cauda R, et al. Antimicrob Agents Chemother 2007 51 6 1987 1994 10.1128/AAC.01509-06 17387156 (Pubitemid 46903084)
5. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Giske CG, Monnet DL, Cars O, Carmeli Y, Antimicrob Agents Chemother 2008 52 3 813 821 10.1128/AAC.01169-07 18070961 (Pubitemid 351358357)
6. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Fridkin SK, Edwards JR, Tenover FC, Gaynes RP, McGowan JE, Clin Infect Dis 2001 33 3 324 330 10.1086/321893 11438897 (Pubitemid 32664835)
7. The utility of hospital antibiograms as tools for guiding empiric therapy and tracking resistance. Insights from the Society of Infectious Diseases Pharmacists. Pakyz AL, Pharmacotherapy 2007 27 9 1306 1312 10.1592/phco.27.9. 1306 17723084 (Pubitemid 47339128)
8. Evaluating antibiograms to monitor drug resistance. El-Azizi M, Mushtaq A, Drake C, Lawhorn J, Barenfanger J, Verhulst S, Khardori N, Emerg Infect Dis 2005 11 8 1301 1302 16102325 (Pubitemid 41045344)
9. Evaluation of the new VITEK 2 card for identification of clinically relevant gram-negative rods. Funke G, Funke-Kissling P, J Clin Microbiol 2004 42 9 4067 4071 10.1128/JCM.42.9.4067-4071.2004 15364991 (Pubitemid 39296125)
10. Phoenix 100 versus Vitek 2 in the identification of gram-positive and gram-negative bacteria: a comprehensive meta-analysis. Chatzigeorgiou KS, Sergentanis TN, Tsiodras S, Hamodrakas SJ, Bagos PG, J Clin Microbiol 2011 49 9 3284 3291 10.1128/JCM.00182-11 21752980
11. CLSI: M07-A8, Methods for dilution antimicrobial susceptibility tests forbacteria that grow aerobically; approved standard Wayne, PAClinical and Laboratory Standards Institute 2009 14978938
12. CLSI: M100S21, Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement Wayne, PA: Clinical and Laboratory Standards Institute 2011 22723648
13. Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing Group. Barry AL, Fuchs PC, Jones RN, Diagn Microbiol Infect Dis 1989 12 5 413 420 10.1016/0732-8893(89) 90112-0 2612129 (Pubitemid 20026915)
14. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, Vatopoulos A, Gniadkowski M, Toth A, Pfeifer Y, et al. Euro Surveill 2010 15 46
15. CLSI: M02-A11, Performance standards for antimicrobial disk susceptibility tests; approved standard-Eleventh edition Wayne, PA: Clinical and Laboratory Standards Institute 2012 21696255
16. CLSI, Performance Standards for antimicrobial susceptibility testing: Twentieth informational supplement (June 2010 update) Wayne, PA: Clinical and Laboratory Standards Institute 2010
17. Breakpoints for extended-spectrum beta-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations. MacGowan A, Clin Microbiol Infect 2008 14 Suppl 1 166 168 18154541
18. Molecular characterization and antimicrobial susceptibility of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, Mexico. Garza-Gonzalez E, Mendoza Ibarra SI, Llaca-Diaz JM, Gonzalez GM, J Med Microbiol 2011 60 Pt 1 84 90 20930052
19. Extended-spectrum beta-lactamase-producing enterobacteriaceae causing nosocomial infections in Mexico. A retrospective and multicenter study. Silva-Sanchez J, Garza-Ramos JU, Reyna-Flores F, Sanchez-Perez A, Rojas-Moreno T, Andrade-Almaraz V, Pastrana J, Castro-Romero JI, Vinuesa P, Barrios H, et al. Archives Med Res 2011 42 2 156 162 10.1016/j.arcmed.2011.02.004
20. Dissemination of a bla(VIM-2)-carrying integron among Enterobacteriaceae species in Mexico: report from the SENTRY Antimicrobial Surveillance Program. Morfin-Otero R, Rodriguez-Noriega E, Deshpande LM, Sader HS, Castanheira M, Microb Drug Resist 2009 15 1 33 35 10.1089/mdr.2009.0878 19228113
21. Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Quinteros M, Radice M, Gardella N, Rodriguez MM, Costa N, Korbenfeld D, Couto E, Gutkind G, Antimicrob Agents Chemother 2003 47 9 2864 2867 10.1128/AAC.47.9.2864-2867.2003 12936986 (Pubitemid 37040260)
22. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Villegas MV, Correa A, Perez F, Miranda MC, Zuluaga T, Quinn JP, Diagn Microbiol Infect Dis 2004 49 3 217 222 10.1016/j.diagmicrobio.2004.03.001 15246513 (Pubitemid 38891730)
23. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Sader HS, Castanheira M, Mendes RE, Toleman M, Walsh TR, Jones RN, Int J Antimicrob Agents 2005 25 1 57 61 10.1016/j.ijantimicag.2004.08.013 15620827 (Pubitemid 40023347)
24. Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae. Castanheira M, Sader HS, Jones RN, Microb Drug Resist 2010 16 1 61 65 10.1089/mdr.2009.0031 20192819
25. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Nordmann P, Cuzon G, Naas T, Lancet Infect Dis 2009 9 4 228 236 10.1016/S1473-3099(09)70054-4 19324295
26. Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa. Tam VH, Chang KT, Abdelraouf K, Brioso CG, Ameka M, McCaskey LA, Weston JS, Caeiro JP, Garey KW, Antimicrob Agents Chemother 2010 54 3 1160 1164 10.1128/AAC.01446-09 20086165.